Imperative Care’s Kandu Health today announced positive data supporting its digital post-acute stroke treatment platforms.
Campbell, California-based Kandu shared data at two conferences. It presented results from a study of its remote post-acute service at the Society of Vascular and Interventional Neurology (SVIN) Annual Meeting. The company presented feasibility data on its navigation platform at the Association of Neurovascular Clinicians (ANVC) Annual Conference.
CEO Kirsten Carroll was on an episode of MedtechWOMEN Talks. Watch NOW:
Listen NOW:
Kandu Health’s first presentation
Preliminary outcomes from the first graduates of its remote post-acute service demonstrated improved readmission rates. Of the first 60 graduates, Kandu saw all-cause patient readmission rates of 4% at 30 days and 10% at 90 days. That registers at less than half of historically published unplanned readmission rates in similar populations.
Additionally, Kandu saw 97% medication adherence and 92% of patients completed a neurology follow-up. The company said 100% of patients established a relationship with a primary care provider.
“For our first evidence presented at an academic conference, our goal was to share preliminary outcomes for the patients cared for to date, and demonstrate the feasibility of delivering remote telemedicine services to post-acute stroke survivors,” said Dr. Tudor Jovin, Kandu Health chief medical officer. “We are excited about the insights and promise demonstrated in these outcomes and look forward to building on this body of work in the coming year.”
The other study
The company’s other study evaluated how post-stroke impairments, social determinants of health and the presence of a care partner impact survivor engagement and outcomes in a remote post-acute stroke navigation program.
Jennifer Patterson of CHI Memorial Neuroscience Institute led the poster evaluation in this case. She said the evaluation demonstrated “the significant need and opportunity for these services.” Additionally, she said Kandu’s ability to engage and support patients “is encouraging.”
“We are excited to see the strong signal from this recent evidence that this work is important, our services are accessible to the communities they serve, and the outcomes we are generating are meaningful,” said Kirsten Carroll, CEO of Kandu Health. “We look forward to continued partnership with our stakeholders to generate additional clinical evidence that demonstrates our value and informs policy and standard of care for stroke survivors.”
